$GTHP
GUIDED THERAPEUTICS INC

2023 Q4 Form 10-Q Financial Statement

#000147793223008286 Filed on November 13, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3 2022 Q3
Revenue $32.00K $0.00 $3.000K
YoY Change -100.0% -84.21%
Cost Of Revenue $16.00K $4.000K $0.00
YoY Change -79.75% -100.0%
Gross Profit $16.00K -$4.000K $3.000K
YoY Change -120.25% -233.33% -113.04%
Gross Profit Margin 50.0% 100.0%
Selling, General & Admin $415.0K $550.0K $1.219M
YoY Change -50.0% -54.88% 172.1%
% of Gross Profit 2593.75% 40633.33%
Research & Development $86.00K $69.00K $8.000K
YoY Change 120.51% 762.5% -50.0%
% of Gross Profit 537.5% 266.67%
Depreciation & Amortization -$1.000K $0.00 $1.000K
YoY Change -133.33% -100.0% 0.0%
% of Gross Profit -6.25% 33.33%
Operating Expenses $501.0K $619.0K $1.227M
YoY Change -42.35% -49.55% 164.44%
Operating Profit -$485.0K -$623.0K -$1.224M
YoY Change -48.84% -49.1% 151.33%
Interest Expense -$66.00K $71.00K $155.0K
YoY Change 17.86% -54.19% -73.91%
% of Operating Profit
Other Income/Expense, Net $38.00K -$54.00K $122.0K
YoY Change 245.45% -144.26% -78.02%
Pretax Income -$386.0K -$677.0K -$1.102M
YoY Change -78.64% -38.57% -1720.59%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$469.0K -$677.0K $1.102M
YoY Change -74.74% -161.43% 1520.59%
Net Earnings / Revenue -1465.63% 36733.33%
Basic Earnings Per Share -$0.01 -$0.03
Diluted Earnings Per Share -$0.01 -$0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 52.10M shares 51.29M shares 36.66M shares
Diluted Shares Outstanding 51.47M shares 34.83M shares

Balance Sheet

Concept 2023 Q4 2023 Q3 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $591.0K $730.0K $2.697M
YoY Change -74.45% -72.93% 398.52%
Cash & Equivalents $591.0K $731.0K $2.697M
Short-Term Investments
Other Short-Term Assets $163.0K $192.0K $169.0K
YoY Change 18.98% 13.61% -2.31%
Inventory $632.0K $648.0K $596.0K
Prepaid Expenses
Receivables $7.000K $7.000K $29.00K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.393M $1.578M $3.491M
YoY Change -53.63% -54.8% 162.88%
LONG-TERM ASSETS
Property, Plant & Equipment $259.0K $35.00K $42.00K
YoY Change 516.67% -16.67% 281.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $17.00K $17.00K $17.00K
YoY Change 0.0% 0.0% 0.0%
Total Long-Term Assets $276.0K $299.0K $380.0K
YoY Change -23.76% -21.32% -8.65%
TOTAL ASSETS
Total Short-Term Assets $1.393M $1.578M $3.491M
Total Long-Term Assets $276.0K $299.0K $380.0K
Total Assets $1.669M $1.877M $3.871M
YoY Change -50.42% -51.51% 121.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.023M $2.153M $2.217M
YoY Change -7.46% -2.89% -0.14%
Accrued Expenses $833.0K $807.0K $1.050M
YoY Change -33.2% -23.14% 3087.13%
Deferred Revenue
YoY Change
Short-Term Debt $1.262M $1.270M $686.0K
YoY Change 338.19% 85.13% -20.33%
Long-Term Debt Due $39.00K $0.00 $32.00K
YoY Change 129.41% -100.0% 77.78%
Total Short-Term Liabilities $4.809M $4.834M $5.146M
YoY Change -1.23% -6.06% 1.38%
LONG-TERM LIABILITIES
Long-Term Debt $511.0K $510.0K $0.00
YoY Change -100.0%
Other Long-Term Liabilities $155.0K $180.0K $267.0K
YoY Change -38.25% -32.58% -28.42%
Total Long-Term Liabilities $666.0K $693.0K $1.376M
YoY Change -51.74% -49.64% -21.19%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.809M $4.834M $5.146M
Total Long-Term Liabilities $666.0K $693.0K $1.376M
Total Liabilities $5.475M $5.527M $6.522M
YoY Change -12.39% -15.26% -4.4%
SHAREHOLDERS EQUITY
Retained Earnings -$151.1M -$150.6M -$145.5M
YoY Change 2.55% 3.54% 2.55%
Common Stock $3.441M $3.439M $3.432M
YoY Change 0.12% 0.2% 0.85%
Preferred Stock
YoY Change
Treasury Stock (at cost) $132.0K $132.0K $132.0K
YoY Change 0.0% 0.0% 0.0%
Treasury Stock Shares
Shareholders Equity -$3.806M -$3.650M -$2.651M
YoY Change
Total Liabilities & Shareholders Equity $1.669M $1.877M $3.871M
YoY Change -50.42% -51.51% 121.96%

Cashflow Statement

Concept 2023 Q4 2023 Q3 2022 Q3
OPERATING ACTIVITIES
Net Income -$469.0K -$677.0K $1.102M
YoY Change -74.74% -161.43% 1520.59%
Depreciation, Depletion And Amortization -$1.000K $0.00 $1.000K
YoY Change -133.33% -100.0% 0.0%
Cash From Operating Activities -$336.0K -$470.0K -$612.0K
YoY Change -0.59% -23.2% -17.19%
INVESTING ACTIVITIES
Capital Expenditures $3.000K
YoY Change -160.0%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 $3.000K
YoY Change -100.0% -100.0% -160.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 194.0K -150.0K 2.860M
YoY Change -561.9% -105.24% 687.88%
NET CHANGE
Cash From Operating Activities -336.0K -470.0K -612.0K
Cash From Investing Activities 0.000 0.000 3.000K
Cash From Financing Activities 194.0K -150.0K 2.860M
Net Change In Cash -142.0K -620.0K 2.251M
YoY Change -62.92% -127.54% -690.81%
FREE CASH FLOW
Cash From Operating Activities -$336.0K -$470.0K -$612.0K
Capital Expenditures $3.000K
Free Cash Flow -$615.0K
YoY Change -16.21%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2313000 usd
gthp Gain From Extinguishment Of Debt
GainFromExtinguishmentOfDebt
345000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
5000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000924515
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
818000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
48596000 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
52042000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2022Q4 gthp Shares Of Common Stock Issued
SharesOfCommonStockIssued
48595715 shares
CY2022Q4 us-gaap Common Unit Outstanding
CommonUnitOutstanding
48595715 shares
CY2023Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.41
gthp Fair Value Assumption Expected Dividend Rate
FairValueAssumptionExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2019Q3 gthp Consideration Received
ConsiderationReceived
885144 usd
gthp Recognized Expenses For The Warrants
RecognizedExpensesForTheWarrants
0 usd
gthp Expenses For The Warrants
ExpensesForTheWarrants
0 usd
CY2019Q3 gthp Escrow Agent Rate Per Share
EscrowAgentRatePerShare
1.90
gthp Unecognized Expenses For Warrants Issued
UnecognizedExpensesForWarrantsIssued
0 usd
CY2023Q3 gthp Short Term Notes Payable Due To Related Parties
ShortTermNotesPayableDueToRelatedParties
0 usd
gthp Loss On Extinguishment Of Debt
LossOnExtinguishmentOfDebt
123038 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Entity File Number
EntityFileNumber
000-22179
dei Entity Registrant Name
EntityRegistrantName
GUIDED THERAPEUTICS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
58-2029543
dei Entity Address Address Line1
EntityAddressAddressLine1
5835 Peachtree Corners East
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite B
dei Entity Address City Or Town
EntityAddressCityOrTown
Peachtree Corners
dei Entity Address State Or Province
EntityAddressStateOrProvince
GA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
30092
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
242-8723
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52096121 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
731000 usd
CY2023Q3 us-gaap Revenues
Revenues
0 usd
CY2022Q3 us-gaap Revenues
Revenues
3000 usd
us-gaap Revenues
Revenues
66000 usd
us-gaap Revenues
Revenues
13000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
46000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-4000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
3000 usd
us-gaap Gross Profit
GrossProfit
20000 usd
us-gaap Gross Profit
GrossProfit
11000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
69000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
8000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
142000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
38000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
69000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
52000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
203000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
129000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
481000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1167000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2647000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2229000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
619000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
1227000 usd
us-gaap Operating Expenses
OperatingExpenses
2992000 usd
us-gaap Operating Expenses
OperatingExpenses
2396000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-623000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1224000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2972000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2385000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
71000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
155000 usd
us-gaap Interest Expense
InterestExpense
206000 usd
us-gaap Interest Expense
InterestExpense
512000 usd
CY2023Q3 gthp Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
0 usd
CY2022Q3 gthp Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
5000 usd
gthp Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
5000 usd
gthp Change In Fair Value Of Derivative Liability
ChangeInFairValueOfDerivativeLiability
13000 usd
CY2023Q3 gthp Gain From Extinguishment Of Debt
GainFromExtinguishmentOfDebt
17000 usd
CY2022Q3 gthp Gain From Extinguishment Of Debt
GainFromExtinguishmentOfDebt
270000 usd
gthp Gain From Extinguishment Of Debt
GainFromExtinguishmentOfDebt
69000 usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-54000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
122000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-131000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-149000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-677000 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-1102000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-3103000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-2534000 usd
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-677000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-1102000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3103000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2534000 usd
CY2023Q3 gthp Deemed Dividend For Warrant Exchanges
DeemedDividendForWarrantExchanges
0 usd
CY2022Q3 gthp Deemed Dividend For Warrant Exchanges
DeemedDividendForWarrantExchanges
0 usd
gthp Deemed Dividend For Warrant Exchanges
DeemedDividendForWarrantExchanges
-65000 usd
gthp Deemed Dividend For Warrant Exchanges
DeemedDividendForWarrantExchanges
0 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
40000 usd
CY2022Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
48000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
122000 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
581000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-717000 usd
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1054000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3290000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3115000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.07
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.11
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.11
CY2023Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
51473000 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
34829000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
50588000 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
27335000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
51473000 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
34829000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
50588000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
27335000 shares
CY2023Q2 gthp Stockholdars Equity
StockholdarsEquity
-3315000 usd
CY2023Q3 gthp Issuance Of Common Stock For Payment Of Series D Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount
8000 usd
CY2023Q3 gthp Issuance Of Common Stock For Payment Of Series E Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount
53000 usd
CY2023Q3 gthp Issuance Of Common Stock For Payment Of Interest Amount
IssuanceOfCommonStockForPaymentOfInterestAmount
60000 usd
CY2023Q3 gthp Settlement Of Previously Accrued Professional Fees Through Common Stock Issuance Amount
SettlementOfPreviouslyAccruedProfessionalFeesThroughCommonStockIssuanceAmount
51000 usd
CY2023Q3 gthp Stockbasedcompensation
Stockbasedcompensation
210000 usd
CY2023Q3 gthp Accruedpreferreddividends
Accruedpreferreddividends
-40000 usd
CY2023Q3 gthp Net Income Losses
NetIncomeLosses
-677000 usd
CY2023Q3 gthp Stockholdars Equity
StockholdarsEquity
-3650000 usd
CY2022Q4 gthp Stockholdars Equity
StockholdarsEquity
-2883000 usd
gthp Common Stock Warrants Exercised Amount
CommonStockWarrantsExercisedAmount
231000 usd
gthp Issuance Of Common Stock For Payment Of Series D Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount
22000 usd
gthp Issuance Of Common Stock For Payment Of Series E Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount
61000 usd
CY2023Q3 gthp Issuance Of Common Stock For Payment Of Series E Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount
53000 usd
gthp Issuance Of Common Stock For Payment Of Series F2 Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesF2PreferredDividendsAmount
29000 usd
gthp Issuance Of Common Stock For Payment Of Interest Amount
IssuanceOfCommonStockForPaymentOfInterestAmount
119000 usd
gthp Settlement Of Previously Accrued Professional Fees Through Common Stock Issuance Amount
SettlementOfPreviouslyAccruedProfessionalFeesThroughCommonStockIssuanceAmount
168000 usd
gthp Stockbasedcompensation
Stockbasedcompensation
1776000 usd
gthp Accruedpreferreddividends
Accruedpreferreddividends
-123000 usd
gthp Net Income Losses
NetIncomeLosses
-3103000 usd
CY2023Q3 gthp Stockholdars Equity
StockholdarsEquity
-3650000 usd
CY2022Q2 gthp Stockholdars Equity
StockholdarsEquity
-5766000 usd
CY2022Q3 gthp Issuances Of Common Stock To Investors Amount
IssuancesOfCommonStockToInvestorsAmount
1396000 usd
CY2022Q3 gthp Proceeds From Issuance Of Warrants New
ProceedsFromIssuanceOfWarrantsNew
1796000 usd
CY2022Q3 gthp Issuance Of Common Stock For Payment Of Series D Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount
10000 usd
CY2022Q3 gthp Issuance Of Common Stock For Payment Of Series E Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount
67000 usd
CY2022Q3 gthp Issuance Of Common Stock For Payment Of Interest Amount
IssuanceOfCommonStockForPaymentOfInterestAmount
70000 usd
CY2022Q3 gthp Stockbasedcompensation
Stockbasedcompensation
44000 usd
CY2022Q3 gthp Issuances Of Warrants To Consultants
IssuancesOfWarrantsToConsultants
786000 usd
CY2022Q3 gthp Accrued Preferred Dividents
AccruedPreferredDividents
48000 usd
CY2022Q3 gthp Net Income Losses
NetIncomeLosses
-1102000 usd
CY2022Q3 gthp Stockholdars Equity
StockholdarsEquity
-2651000 usd
CY2021Q4 gthp Stockholdars Equity
StockholdarsEquity
-5445000 usd
gthp Common Stock Warrants Exercised Amount
CommonStockWarrantsExercisedAmount
846000 usd
CY2022Q3 gthp Issuances Of Common Stock To Investors Amount
IssuancesOfCommonStockToInvestorsAmount
1396000 usd
CY2022Q3 gthp Proceeds From Issuance Of Warrants New
ProceedsFromIssuanceOfWarrantsNew
1796000 usd
gthp Issuance Of Common Stock For Payment Of Series D Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesDPreferredDividendsAmount
39000 usd
gthp Issuance Of Common Stock For Payment Of Series E Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesEPreferredDividendsAmount
102000 usd
gthp Issuance Of Common Stock For Payment Of Series F Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesFPreferredDividendsAmount
107000 usd
gthp Issuance Of Common Stock For Payment Of Series F2 Preferred Dividends Amount
IssuanceOfCommonStockForPaymentOfSeriesF2PreferredDividendsAmount
75000 usd
gthp Issuance Of Common Stock For Payment Of Interest Amount
IssuanceOfCommonStockForPaymentOfInterestAmount
150000 usd
gthp Stockbasedcompensationn
Stockbasedcompensationn
132000 usd
gthp Issurance Of Warrrants To Consultants
IssuranceOfWarrrantsToConsultants
865000 usd
gthp Accruedpreferreddividends
Accruedpreferreddividends
-581000 usd
gthp Net Income Losses
NetIncomeLosses
-2534000 usd
CY2022Q3 gthp Stockholdars Equity
StockholdarsEquity
-2651000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3103000 usd
us-gaap Net Income Loss
NetIncomeLoss
-2534000 usd
us-gaap Interest Paid
InterestPaid
97000 usd
us-gaap Interest Paid
InterestPaid
89000 usd
CY2023Q3 gthp Working Capital
WorkingCapital
-3300000 usd
CY2023Q3 gthp Retained Earning Accumulated Deficit
RetainedEarningAccumulatedDeficit
-150600000 usd
gthp Net Loss Preferred Dividend
NetLossPreferredDividend
-3300000 usd
CY2023Q3 gthp Preconfirmations Stockholders Equity
PreconfirmationsStockholdersEquity
-3700000 usd
us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
195000 usd
CY2022 us-gaap Proceeds From Sale Of Trust Assets To Pay Expenses
ProceedsFromSaleOfTrustAssetsToPayExpenses
3200000 usd
CY2022 us-gaap Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants
ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants
532000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant areas where estimates are used include the allowance for doubtful accounts, inventory valuation and input variables for Black-Scholes and binomial option pricing models. The Company uses the binomial option pricing model for the calculation of the fair value of freestanding warrants with market conditions.</p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The Company maintains a cash balance in a financial institution that is insured by the Federal Deposit Insurance Corporation up to certain federal limitations. At times, the Company’s cash balance exceeds these federal limitations. The amount in excess of insured limitations was approximately $482,776 and $2,064,772 as of September 30, 2023 and December 31, 2022, respectively.</p>
CY2023Q3 gthp Excessed Amount Of Insured Limitations
ExcessedAmountOfInsuredLimitations
482776 usd
CY2022Q4 gthp Excessed Amount Of Insured Limitations
ExcessedAmountOfInsuredLimitations
2064772 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
1364000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
1260000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
58000 usd
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
68000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
44000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
38000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
818000 usd
CY2022Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
818000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
648000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
548000 usd
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1792000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1792000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1757000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1750000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
35000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42000 usd
CY2023Q3 us-gaap Depreciation Nonproduction
DepreciationNonproduction
2316000 usd
us-gaap Depreciation Nonproduction
DepreciationNonproduction
6947000 usd
CY2023Q3 us-gaap Accrued Bonuses Current And Noncurrent
AccruedBonusesCurrentAndNoncurrent
374000 usd
CY2023Q3 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
141000 usd
CY2023Q3 gthp Accrued Stock Subscription Payable
AccruedStockSubscriptionPayable
0 usd
CY2022Q4 gthp Accrued Stock Subscription Payable
AccruedStockSubscriptionPayable
36000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
189000 usd
CY2022Q4 us-gaap Accrued Vacation Current And Noncurrent
AccruedVacationCurrentAndNoncurrent
41000 usd
CY2022Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
231000 usd
CY2023Q3 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
7000 usd
CY2023Q3 us-gaap Accrued Liabilities Current And Noncurrent
AccruedLiabilitiesCurrentAndNoncurrent
807000 usd
CY2023Q3 us-gaap Deferred Revenue
DeferredRevenue
450516 usd
CY2023Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
8942 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1500 usd
CY2023Q3 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
7442 usd
CY2022Q4 us-gaap Revenue Remaining Performance Obligation
RevenueRemainingPerformanceObligation
6312 usd
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
221143 usd
CY2023Q3 us-gaap Accretion Expense
AccretionExpense
83366 usd
CY2022 us-gaap Accretion Expense
AccretionExpense
166667 usd
CY2019Q4 gthp Derivative Liability Bifurcated Conversion Option Actus Loan Amount
DerivativeLiabilityBifurcatedConversionOptionActusLoanAmount
326016 usd
CY2022Q4 us-gaap Derivative Liabilities
DerivativeLiabilities
-5000 usd
gthp Summary Of Changes To Level Three Instruments
SummaryOfChangesToLevelThreeInstruments
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: #000000 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(in thousands)</strong> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Derivative</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" colspan="2" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance at December 31, 2022</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">$</td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">(5</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">)</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Change in fair value during the period</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 1px solid;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:right;">5</td><td style="PADDING-BOTTOM: 1px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Balance at September 30, 2023</strong></p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="BORDER-BOTTOM: 3px double;width:1%;vertical-align:bottom;white-space: nowrap;"><strong>$</strong></td><td class="ffcell" style="BORDER-BOTTOM: 3px double;width:9%;vertical-align:bottom;text-align:right;"><strong>-</strong></td><td style="PADDING-BOTTOM: 3px;width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr></tbody></table>
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Unit Outstanding
CommonUnitOutstanding
52041502 shares
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
3445787 shares
us-gaap Common Stock Dividends Shares
CommonStockDividendsShares
3445787 shares
CY2022Q4 us-gaap Shares Outstanding
SharesOutstanding
48595715 shares
CY2023Q3 us-gaap Shares Outstanding
SharesOutstanding
52041502 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
35586980 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
6773750 shares
gthp Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Warrant Issued
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePriceWarrantIssued
0.26
gthp Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Warrants Exchanged
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsWarrantsExchanged
-1025000 usd
gthp Share Based Compensation Arrangement By Share Based Payment Award Options For Exchange In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForExchangeInPeriodWeightedAverageExercisePrice
0.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations
9545200 shares
gthp Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price Expired
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePriceExpired
0.30
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
973750 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.20
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
30816780 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.49
gthp Schedule Of Fair Value Warrants Issued Under Black Scholes Option Pricing Model Table Textblock
ScheduleOfFairValueWarrantsIssuedUnderBlackScholesOptionPricingModelTableTextblock
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Expected term (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.8</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Volatility</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">266.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Risk-free interest rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.8</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Dividend yield</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">0.0</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
2.664 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.038 pure
CY2023Q3 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.10 pure
CY2023Q1 gthp Vesting Period Description
VestingPeriodDescription
One fourth of the stock options vested immediately, while the remaining options will vest over a period of 33 months, beginning on May 10, 2023
CY2023Q1 gthp Vesting Period Description
VestingPeriodDescription
One fourth of the stock options vested immediately, while the remaining options will vest over a period of 33 months, beginning on June 7, 2023
gthp Stock Based Compensation Expense
StockBasedCompensationExpense
221143 usd
gthp Stock Based Compensation Expense
StockBasedCompensationExpense
131735 usd
gthp Outstanding At Beginning Of Year
OutstandingAtBeginningOfYear
1500000 shares
CY2022Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.49
gthp Weighted Average Remaining Contractual Life Beginning
WeightedAverageRemainingContractualLifeBeginning
P7Y6M
CY2022Q4 gthp Agrregate Intrensic Value
AgrregateIntrensicValue
0 usd
gthp Options Granted
OptionsGranted
1025000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.26
gthp Share Based Compensation Arrangement By Share Based Payment Award Option Forfeiture In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeitureInPeriod
-186364 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.31
gthp Outstanding End
OutstandingEnd
2338636 shares
gthp Weighted Average Remaining Contractual Life Ending
WeightedAverageRemainingContractualLifeEnding
P6Y9M18D
CY2022Q3 gthp Agrregate Intrensic Value
AgrregateIntrensicValue
0 usd
gthp Number Of Shares Exercisable
NumberOfSharesExercisable
1811364 shares
gthp Weighted Average Exercise Price Per Share Exercisable
WeightedAverageExercisePricePerShareExercisable
0.45
gthp Weighted Average Remaining Contractual Life Exercisable
WeightedAverageRemainingContractualLifeExercisable
P6Y
gthp Agrregate Intrensic Value Exercisable
AgrregateIntrensicValueExercisable
0 usd
gthp Outstanding End
OutstandingEnd
1500000 shares
CY2022Q3 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.49
gthp Weighted Average Remaining Contractual Life Ending
WeightedAverageRemainingContractualLifeEnding
P7Y9M18D
CY2023Q3 gthp Agrregate Intrensic Value
AgrregateIntrensicValue
0 usd
gthp Number Of Shares Exercisable
NumberOfSharesExercisable
1227136 shares
gthp Weighted Average Exercise Price Per Share Exercisable
WeightedAverageExercisePricePerShareExercisable
0.49
gthp Weighted Average Remaining Contractual Life Exercisable
WeightedAverageRemainingContractualLifeExercisable
P7Y9M18D
gthp Agrregate Intrensic Value Exercisable
AgrregateIntrensicValueExercisable
0 usd
gthp Unrecognized Stock Based Compensation Expense
UnrecognizedStockBasedCompensationExpense
139088 usd
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y6M
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.26
gthp Expected Term Years
ExpectedTermYears
P10Y
gthp Fair Value Assumption Expected Volatility Rate
FairValueAssumptionExpectedVolatilityRate
3.664 pure
gthp Fair Value Assumption Risk Free Interest Rate
FairValueAssumptionRiskFreeInterestRate
0.038 pure
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
247000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
303000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
267000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
325000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
28000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
115000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
118000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
50000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
311000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
44000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
267000 usd
gthp Schedule Of Weighted Average Remaining Lease Term And Discount Rate
ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRate
<table cellpadding="0" style="border-spacing:0;text-align:left;font:10pt times new roman;width:100%"><tbody><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="6" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>(in thousands)</strong></p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>September 30,</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>2023</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="hdcell" colspan="2" style="BORDER-BOTTOM: 1px solid;width:9%;vertical-align:bottom;text-align:center;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>December 31,</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>2022</strong></p></td><td style="PADDING-BOTTOM: 1px;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average remaining lease term (years)</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">2.7</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">3.4</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Weighted average discount rate</p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td style="width:1%;white-space: nowrap;"><p style="font-size:10pt;font-family:times new roman;margin:0px"> </p></td><td class="ffcell" style="width:9%;vertical-align:bottom;text-align:right;">11.4</td><td style="width:1%;vertical-align:bottom;white-space: nowrap;">%</td></tr></tbody></table>
us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P2Y8M12D
CY2022 us-gaap Finite Lived Intangible Asset Weighted Average Period Before Next Renewal Or Extension
FiniteLivedIntangibleAssetWeightedAveragePeriodBeforeNextRenewalOrExtension
P3Y4M24D
gthp Weighted Average Discount Rateoperating Lease
WeightedAverageDiscountRateoperatingLease
0.114 pure
CY2022 gthp Weighted Average Discount Rateoperating Lease
WeightedAverageDiscountRateoperatingLease
0.114 pure
CY2016Q2 gthp Royalty Percent
RoyaltyPercent
0.20 pure
CY2020Q1 gthp Warrants Broken Into Four Tranches
WarrantsBrokenIntoFourTranches
1250000 shares
CY2020Q1 us-gaap Share Price
SharePrice
0.25
CY2023Q3 gthp Shares Exchange
SharesExchange
750000 shares
CY2023Q3 us-gaap Share Price
SharePrice
0.25
CY2019Q4 us-gaap Share Price
SharePrice
0.40
gthp Expenses For The Warrants
ExpensesForTheWarrants
307457 usd
CY2022Q4 gthp Debt Issuance Costs Amortized
DebtIssuanceCostsAmortized
-40000 usd
CY2023Q3 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
64000 usd
CY2022Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
140000 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
1048000 usd
CY2022Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
950000 usd
CY2022Q3 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
123889 usd
CY2022Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
11409 usd
CY2022Q3 gthp Accrued Interest Rate
AccruedInterestRate
0.050 pure
CY2022Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2023-05-04
CY2022Q4 us-gaap Notes Payable
NotesPayable
56569 usd
CY2023Q3 us-gaap Line Of Credit Facility Average Outstanding Amount
LineOfCreditFacilityAverageOutstandingAmount
129073 usd
CY2023Q3 us-gaap Repayments Of Debt
RepaymentsOfDebt
12041 usd
CY2023Q3 gthp Accrued Interest Rate
AccruedInterestRate
0.079 pure
CY2023Q3 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2024-05-04
CY2023Q3 us-gaap Notes Payable
NotesPayable
94152 usd
CY2023Q3 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
94000 usd
CY2022Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
58000 usd
CY2022Q4 gthp Short Term Notes Payable Due To Related Parties
ShortTermNotesPayableDueToRelatedParties
619 usd
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
2400000 usd
CY2023Q3 us-gaap Debt Instrument Interest Rate Stated Percentage
DebtInstrumentInterestRateStatedPercentage
0.24 pure
gthp Convertible Debt Conversion Price Description
ConvertibleDebtConversionPriceDescription
variable conversion price was 95% multiplied by the market price (the market price means the average of the five lowest trading prices during the period beginning on the issue date and ending on the maturity date
CY2019Q4 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.04
CY2019Q4 gthp Variable Conversion Price
VariableConversionPrice
0.15
CY2022Q3 gthp Early Repayment Of Senior Debt Penalty
EarlyRepaymentOfSeniorDebtPenalty
350000 usd
CY2022Q3 gthp Default Premiums
DefaultPremiums
281256 usd
CY2022Q3 gthp Interest Payable
InterestPayable
91555 usd
CY2022Q3 gthp Amount Reduce After Exchange
AmountReduceAfterExchange
710911 usd
CY2022Q3 gthp Warrant Exchange
WarrantExchange
8775000 shares
CY2022Q3 gthp Debt Instrument Default Penalty Forgiven
DebtInstrumentDefaultPenaltyForgiven
225444 usd
CY2023Q3 gthp Senior Unsecured Convertible Debentures
SeniorUnsecuredConvertibleDebentures
1130000 usd
CY2022Q4 gthp Senior Unsecured Convertible Debentures
SeniorUnsecuredConvertibleDebentures
1130000 usd
CY2023Q3 gthp Debt Issuance Costs Amortized
DebtIssuanceCostsAmortized
-18000 usd
CY2022Q4 gthp Outstanding Principal Longterm Debt
OutstandingPrincipalLongtermDebt
17052 usd
CY2022Q4 gthp Accrued Interest
AccruedInterest
5139 usd
us-gaap Profit Loss
ProfitLoss
-3290 usd
us-gaap Profit Loss
ProfitLoss
-3115 usd
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
50588 shares
us-gaap Weighted Average Number Basic Shares Outstanding Adjustment Pro Forma
WeightedAverageNumberBasicSharesOutstandingAdjustmentProForma
27335 shares
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.07
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.11
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
50588 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
27335 shares
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.07
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-0.11

Files In Submission

Name View Source Status
0001477932-23-008286-index-headers.html Edgar Link pending
0001477932-23-008286-index.html Edgar Link pending
0001477932-23-008286.txt Edgar Link pending
0001477932-23-008286-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gthp-20230930.xsd Edgar Link pending
gthp_10q.htm Edgar Link pending
gthp_ex31.htm Edgar Link pending
gthp_ex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
gthp-20230930_cal.xml Edgar Link unprocessable
gthp-20230930_def.xml Edgar Link unprocessable
gthp-20230930_lab.xml Edgar Link unprocessable
gthp-20230930_pre.xml Edgar Link unprocessable
gthp_10q_htm.xml Edgar Link completed
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending